About 14 results found for searched term "Octapeptide-2" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M51415 | Cholecystokinin Octapeptide (1-2) (desulfated) | Others |
| Cholecystokinin Octapeptide (1-2) (desulfated) (H-Asp-Tyr-OH) is a polypeptide that can be found by peptide screening. | ||
| M52833 | Octapeptide-2 | ROS |
| Octapeptide-2 is a bioactive peptide with promotion of hair growth effect and has been reported used as a cosmetic ingredient. | ||
| M10309 | CYN 154806 TFA | Peptides |
| CYN 154806 TFA is a cyclic octapeptide and an effective selective somatostatin sst2 receptor antagonist. | ||
| M10570 | Adrenorphin (Metorphamide) | Opioid Receptor |
| Metorphamide; Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-NH2 | ||
| Adrenorphin (Metorphamide) is a opioid octapeptide, acting as a potent agonist of μ-opioid receptor, with Ki of 12 nM. | ||
| M11321 | Angiopeptin TFA | Somatostatin Receptor |
| Angiopeptin TFA, a cyclic octapeptide analog of somatostatin, is an SST2 / SST5 receptor partial agonist with IC50 values of 0.26 nM and 6.92 nM, respectively. Angiopeptin TFA inhibits growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin TFA inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin TFA has the potential to be used in the study of coronary atherosclerosis. | ||
| M14074 | C3a (70-77) (TFA) | Complement System |
| Complement 3a (70-77) (TFA) | ||
| C3a (70-77) TFA (Complement 3a (70-77) TFA) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a. | ||
| M42513 | VPLSLYSG | MMP |
| VPLSLYSG is an octapeptide that can be degraded by matrix metalloproteinase-9 (MMP-9), MMP-1 and MMP-2. | ||
| M43964 | Cholecystokinin (26-33), CCK8 TFA | Others |
| Cholecystokinin Octapeptide, desulfated TFA; CCK Octapeptide, desulfated TFA | ||
| Cholecystokinin (26-33), CCK8 TFA is a synthetic desulfated octapeptide cholecystokinin (CCK). Sequence: Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | ||
| M45380 | Saralasin TFA | Angiotensin Receptor |
| [Sar1,Ala8] Angiotensin II TFA | ||
| Saralasin TFA is an octapeptide analog of Angiotensin II and a competitive angiotensin II receptor antagonist with a Ki value of 0.32 nM (74% of binding sites) and partial agonist activity. It has a Ki value of 0.32 nM (74% of binding sites) and partial agonist activity. It can be used in studies related to renal vascular hypertension and renin-dependent (angiotensinogenic) hypertension. | ||
| M52888 | Angiopeptin | Somatostatin Receptor |
| Angiopeptin, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26 nM and 6.92 nM, respectively. | ||
| M53475 | Peptide T TFA | Anti-infection |
| Peptide T (TFA) is an octapeptide from the V2 region of HIV-1 gp120. | ||
| M54002 | CYN 154806 | Somatostatin Receptor |
| CYN 154806, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist. | ||
| M54318 | Peptide T | Anti-infection |
| Peptide T is an octapeptide from the V2 region of HIV-1 gp120. | ||
| M54443 | Neuropeptide FF | Neuropeptide Receptor |
| Neuropeptide FF (NPFF), an octapeptide belonging to the RF-amide family of peptides, interacts with two distinct G-protein-coupled receptors, NPFF(1) and NPFF(2). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
